🔴 Amneal Pharmaceuticals is trading 4.08% down today after completing Kashiv acquisition with new-share dilution

Amneal Pharmaceuticals is trading at $17.15, down -4.08%, after completing its Kashiv BioSciences acquisition, the clearest company-specific catalyst despite healthcare-sector strength.

• The transaction closed on August 10, 2026, combining cash and stock consideration.
• It includes $375 million cash and approximately 28.9 million new shares, potentially pressuring investors through dilution.
• Volume was approximately 709.59K shares versus 1.86 million average volume.